英豪彩票平台

R&D

英豪彩票平台Adhering to "market-oriented, customer demand as our mission" R&D strategy, our company invests large funds for research and development. We built up a joint laboratory with Shanghai Tongji University, forcusing on veterinary industry tendency and developing non-patent synthetic route of the APIs under patent protection. For the past decade, we have successfully developed Tulathromycin, Gamithromycin, Cefovecin, etc.

辽宁福彩网 乐透乐彩票注册 鑫乐博彩票平台 即发彩票注册 六分彩票官网 彩票投平台注册 河北福彩网 牛逼彩票导航